Literature DB >> 2338817

Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth.

V S Klimberg1, W W Souba, R M Salloum, D A Plumley, F S Cohen, D J Dolson, K I Bland, E M Copeland.   

Abstract

Glutamine is a principal fuel utilized by rapidly growing tumors. Advanced malignant disease results in muscle glutamine depletion and weight loss. Concern exists about providing dietary glutamine to the host with cancer since it may stimulate tumor growth. This study examined the effects of oral glutamine on muscle glutamine metabolism and tumor growth. Twenty-four rats with large sarcomas were pair fed a glutamine-enriched or glutamine-free elemental diet. Diets were isonitrogenous and isocaloric. After 6 days of feeding, the animals were anesthetized and arterial glutamine, hindquarter glutamine flux, muscle glutamine content, tumor weight, tumor DNA content, tumor glutaminase activity, and number of metaphase mitoses/high power field (HPF) in the tumor were determined. There was no difference in arterial glutamine between the two groups, but provision of a glutamine-enriched diet increased muscle glutamine content by 60% (2.31 +/- 0.21 mumole/g tissue vs 1.44 +/- 0.22 mumol/g tissue, P less than 0.05), which supported muscle glutamine release. There were no differences among tumor DNA content, tumor glutaminase activity, or tumor weight and there was no difference histologically in the number of metaphase mitoses/HPF. Glutamine-enriched oral diets may replete host glutamine stores and support muscle glutamine metabolism without stimulating tumor growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338817     DOI: 10.1016/0022-4804(90)90066-b

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

Review 1.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

2.  Effect of glutamine on methotrexate efficacy and toxicity.

Authors:  I T Rubio; Y Cao; L F Hutchins; K C Westbrook; V S Klimberg
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

3.  The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues.

Authors:  T R Austgen; P S Dudrick; H Sitren; K I Bland; E Copeland; W W Souba
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

Review 4.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 5.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.

Authors:  Katharina S Kuhn; Maurizio Muscaritoli; Paul Wischmeyer; Peter Stehle
Journal:  Eur J Nutr       Date:  2009-11-21       Impact factor: 5.614

6.  Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney.

Authors:  M K Chen; N J Espat; K I Bland; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

7.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.

Authors:  R Kinscherf; V Hack; T Fischbach; B Friedmann; C Weiss; L Edler; P Bärtsch; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

8.  Effect of alanylglutamine-enriched infusion on tumor growth and cellular immune function in rats.

Authors:  M N Kweon; S Moriguchi; K Mukai; Y Kishino
Journal:  Amino Acids       Date:  1991-02       Impact factor: 3.520

Review 9.  Glutamine and cancer.

Authors:  W W Souba
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

10.  Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism.

Authors:  K Rouse; E Nwokedi; J E Woodliff; J Epstein; V S Klimberg
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.